Passionate about leading teams that bring together the most advancedscience and technology to make an impact on human disease.
Dr. Alfa is Vice President, Discovery and Product at Recursion Pharmaceuticals (recursionpharma.com), an AI-enabled drug discovery company combining state-of-the-art machine learning with automated cell biology. At Recursion, he leads Product across the organization working closely with all teams to leverage computational tools & robotics to solve important drug discovery challenges. He received training in Neurosciences, Medicine, and Entrepreneurship at Stanford University and has made scientific contributions to the fields of Neurosciences, Metabolism, and Genetics. Prior to Recursion, Dr. Alfa worked closely with biotech start-ups at Stanford-affiliated accelerator, StartX.